April 26th - 29th, 2021
We’ve just released the agenda for our 2021 US Virtual Conference, taking place from April 26th to 29th! Our theme this year is, “Converge, Converse, Connect!” Download the agenda and mark your calendar to join us in April!
Clinical Supply Chains teams in start-up and small sponsor companies do not have the availability of advanced systems, funding and resources. This workshop will discuss some specific challenges and potential solutions, in addition the advantages and disadvantages of working in a less developed organizational environment.
Operational Excellence (OE) is becoming a driver to improve the efficiency when applied to the clinical supply chain. Whether that comes in the form of lean clinical supply chains, better KPIs or automation, it is essential that we implement one, if not more, of these concepts to adapt to ever-changing clinical supply requirements. This workshop will identify the different aspects of Operational Excellence and how they can be used in your clinical supply chain.
Direct-to-patient in clinical trial is not a buzzword anymore, it's a way to continue patient treatment and being patient centric. This mini-presentation is designed to discuss DtP strategies, options to implement when planning a robust direct-to-patient supply chain model, risk management, resilient planning, reverse supply chain from the patient home, accountability and the future of decentralized clinical trials.
As the number of new Cell and Gene therapies grows in the clinical development space, it becomes increasingly important to understand the supply chain challenges of these unique therapies. This workshop will identify and differentiate the challenges of the autologous and allogeneic clinical supply chain requirements
Welcome to 2021! The UK has officially exited the EU and now that we’ve got some experience with clinical trials post Brexit, let’s share some experiences! This workshop will discuss the implications of Brexit on Clinical Supplies – including EU27, the UK and NI.
AI (Artificial Intelligence) or ML (Machine Learning) refers to software technologies that make a robot or computer act and think like a human. This presentation will explain what AI is and discuss how it is being implemented into the Clinical Supply Chain.(1) Describe what AI is and how it can help the clinical supply chain (2) Explain what must be done with the clinical supply chain now in order for us to get the most out of AI (3) Give examples of how AI can be used to accelerate the clinical supply chain
Change is the standard when working within the clinical supply chain. When change must be implemented and adopted, change management becomes essential. The key to change management is not the system being changed, it's the people that must buy into and accept the change to be successful. This workshop will identify ways to ensure people more quickly transistion to the new way of working.
Just-in-time is a key opportunity to resolve issues with clinical supply chains today. However, this strategy involves overcoming significant process and technology barriers in order to drive effective change. This workshop will explore these challenges, along with identifying digital solutions to maximize this opportunity.
As the clinical supply industry continues to outsource more and more operational support, we find that systems integration between sponsor and vendor is essential. This workshop will identify the best ways to link Sponsor companies' internal systems with external vendor systems to create the most efficient clinical supply chain.
Holistic program management evaluates timing and supply for the entire asset lifecycle in order to synchronize demand and supply across all studies. This in turn drives feasibility/supply plans for all phases of the asset. This workshop will discuss the different aspects involved in overall program management rather than protocol-level project management of clinical supply.
The greatest outcome of the pandemic was the accelerated creation and approval of the CoVid-19 vaccines. This workshop will focus on what was learned from the development of the vaccines and how our normal Clinical Supply Chain had to evolve quickly.
Head to the auditorium for today's entertainment!
Ancillary supplies are often the items no one wants to take responsibility for due to their unique procurement and distribution challenges. Over the years they have fallen squarely on the shoulders of clinical supplies folks. This workshop will be a discussion of the various practices used for procuring, stocking, and distributing ancillary items to clinical sites.
The pandemic's impact for the Clinical Supply Chain was intense and educational. Many of our companies adapted quickly to a new way of planning, forecasting and distributing clinical supplies. This workshop will identify a number of new concepts and ideas that have positively affected the Clinical Supply Chain.
With global trials being the standard, it is incredibly important to understand the Customs value of clinical supplies that we have to account for in planning and budgeting for our Clinical Trials. This workshop will explore the different ways to value clinical supplies and how to choose the best way for the attendee.(1) List five (5) different ways to establish drug valuation (2) Identify two (2) common mistakes made when identifying the valuation of IMPs (3) Explain two (2) outcomes of incorrectly valuing our clinical supplies when shipping internationally
We are all well aware of the extensive work that goes into supplying study drug to a clinical site. However, there are many other activities that happen during a patient's visit to a clinical site in addition to dispensing study drug. This workshop will discuss all of those other activities and the people who performs them as well as ways that CT Supplies organizations can help make the entire patient experience less stressful.
Expanding access to patient populations, faster recruitment, increasing patient retention and decreasing time to market are all reasons sponsors shifted to direct-to-patient and decentralized clinical trials. This workshop will focus on the positive aspects and outcomes of the amazing pivot that the industry accomplished in adopting these new models.
With global trials being the standard, it is incredibly important to understand the clinical supplies value and the value added tax we have to account for in budgeting for our Clinical Trials. This workshop will also discuss the importance of Import Licenses and the Importer of Record when shipping globally.
With the rising costs of investigational supplies for clinical trials, it is becoming ever more important to maximize the use of IMP. This session will explore different methods that can be employed through an IRT to best avoid waste and lower the overall cost of a clinical trial. This will cover the study set-up, execution, and close-out phases of a clinical trial with an eye towards optimizing performance.
In order to shorten clinical trial timelines and increase efficiency of the clinical supply chain, it is essential to develop an excellent rapport with our Clinical Operations stakeholders. This workshop will explore how to better partner and collaborate with Clinical Operations in order to get the best out of our clinical supply chain
Clinical Supply Chains teams in start-up and small sponsor companies do not have the availability of advanced systems, funding and resources. This workshop will discuss some specific challenges and potential solutions, in addition the advantages and disadvantages of working in a less developed organizational environment.
Operational Excellence (OE) is becoming a driver to improve the efficiency when applied to the clinical supply chain. Whether that comes in the form of lean clinical supply chains, better KPIs or automation, it is essential that we implement one, if not more, of these concepts to adapt to ever-changing clinical supply requirements. This workshop will identify the different aspects of Operational Excellence and how they can be used in your clinical supply chain.
Stay tuned for more details about the networking & vendor showcase events!
Head to the auditorium for today's entertainment!
Welcome to 2021! The UK has officially exited the EU and now that we’ve got some experience with clinical trials post Brexit, let’s share some experiences! This workshop will discuss the implications of Brexit on Clinical Supplies – including EU27, the UK and NI.
As the clinical supply industry continues to outsource more and more operational support, we find that systems integration between sponsor and vendor is essential. This workshop will identify the best ways to link Sponsor companies' internal systems with external vendor systems to create the most efficient clinical supply chain.
Change is the standard when working within the clinical supply chain. When change must be implemented and adopted, change management becomes essential. The key to change management is not the system being changed, it's the people that must buy into and accept the change to be successful. This workshop will identify ways to ensure people more quickly transistion to the new way of working.
AI (Artificial Intelligence) or ML (Machine Learning) refers to software technologies that make a robot or computer act and think like a human. This presentation will explain what AI is and discuss how it is being implemented into the Clinical Supply Chain.
As the number of new Cell and Gene therapies grows in the clinical development space, it becomes increasingly important to understand the supply chain challenges of these unique therapies. This workshop will identify and differentiate the challenges of the autologous and allogeneic clinical supply chain requirements
Ancillary supplies are often the items no one wants to take responsibility for due to their unique procurement and distribution challenges. Over the years they have fallen squarely on the shoulders of clinical supplies folks. This workshop will be a discussion of the various practices used for procuring, stocking, and distributing ancillary items to clinical sites.
The greatest outcome of the pandemic was the accelerated creation and approval of the CoVid-19 vaccines. This workshop will focus on what was learned from the development of the vaccines and how our normal Clinical Supply Chain had to evolve quickly.
Holistic program management evaluates timing and supply for the entire asset lifecycle in order to synchronize demand and supply across all studies. This in turn drives feasibility/supply plans for all phases of the asset. This workshop will discuss the different aspects involved in overall program management rather than protocol-level project management of clinical supply.
The pandemic's impact for the Clinical Supply Chain was intense and educational. Many of our companies adapted quickly to a new way of planning, forecasting and distributing clinical supplies. This workshop will identify a number of new concepts and ideas that have positively affected the Clinical Supply Chain.
Just-in-time is a key opportunity to resolve issues with clinical supply chains today. However, this strategy involves overcoming significant process and technology barriers in order to drive effective change. This workshop will explore these challenges, along with identifying digital solutions to maximize this opportunity.
Stay tuned for more details about the networking & vendor showcase events!
With global trials being the standard, it is incredibly important to understand the Customs value of clinical supplies that we have to account for in planning and budgeting for our Clinical Trials. This workshop will explore the different ways to value clinical supplies and how to choose the best way for the attendee.
We are all well aware of the extensive work that goes into supplying study drug to a clinical site. However, there are many other activities that happen during a patient's visit to a clinical site in addition to dispensing study drug. This workshop will discuss all of those other activities and the people who performs them as well as ways that CT Supplies organizations can help make the entire patient experience less stressful.
Expanding access to patient populations, faster recruitment, increasing patient retention and decreasing time to market are all reasons sponsors shifted to direct-to-patient and decentralized clinical trials. This workshop will focus on the positive aspects and outcomes of the amazing pivot that the industry accomplished in adopting these new models.
With global trials being the standard, it is incredibly important to understand the clinical supplies value and the value added tax we have to account for in budgeting for our Clinical Trials. This workshop will also discuss the importance of Import Licenses and the Importer of Record when shipping globally.
With the rising costs of investigational supplies for clinical trials, it is becoming ever more important to maximize the use of IMP. This session will explore different methods that can be employed through an IRT to best avoid waste and lower the overall cost of a clinical trial. This will cover the study set-up, execution, and close-out phases of a clinical trial with an eye towards optimizing performance.
In order to shorten clinical trial timelines and increase efficiency of the clinical supply chain, it is essential to develop an excellent rapport with our Clinical Operations stakeholders. This workshop will explore how to better partner and collaborate with Clinical Operations in order to get the best out of our clinical supply chain
Stay tuned for more details about the networking & vendor showcase events!
Don't miss your chance to win some great prizes! Join us in the Auditorium!
Join GCSG to gain full access to our educational resources and our member directory of more than 600 clinical supply colleagues!
